https://abr238901inhibitor.com..../knowledge-ahead-of-
In terms of performance for all outcomes, the PELOD-2 organ dysfunction score held the highest standing. This study aimed to investigate the serum YKL-40 alterations and their predictive value in acute ischemic stroke (AIS) patients diagnosed with diabetes mellitus (DM). In a study of 121 patients with DM and AIS, serum YKL-40 was assessed using ELISA at baseline and on days 1, 3, 7, and 30 subsequent to the initiation of the disease. YKL-40 levels demonstrably increased from the starting point to day 3, then decreased gradually
כמו
תגובה
לַחֲלוֹק
